![Nathan McNally](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Nathan McNally
Entité | Type d'entité | Industrie | |
---|---|---|---|
P4 Precision Medicine Accelerator
![]() P4 Precision Medicine Accelerator Miscellaneous Commercial ServicesCommercial Services P4 Precision Medicine Accelerator is a private company that seeks out leading medtech startups to support through development, regulation, investment, adoption, and scale to UK and international markets to innovate and advance the healthcare landscape. The company is based in Sheffield, South Yorkshire, with a local, national, and international focus. The British company curates an ecosystem of physical space and specialists to support precision medicine innovations to develop research into world-leading technology, support to gain regulatory approval and adoption not only to the healthcare system but scale internationally. The company was founded by Philip Beales, Nathan McNally.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Nathan McNally via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Piper Sandler Ltd.
![]() Piper Sandler Ltd. Investment Banks/BrokersFinance Part of Piper Sandler Cos., Piper Sandler Ltd. is a brokerage services provider. The company is based in London, UK. The British company was founded in 1999. Neil Robert Mackison has been the CEO of the company since 2006. | Investment Banks/Brokers | Analyst-Equity | |
ING Bank NV (United Kingdom) | Investment Banks/Brokers | Analyst-Equity | |
BERGENBIO ASA | Pharmaceuticals: Major | Director/Board Member | |
The Institute of Directors
![]() The Institute of Directors Miscellaneous Commercial ServicesCommercial Services The Institute of Directors provides informative events and professional development courses. The non-profit company is based in Johannesburg, South Africa. Parmesvari Natesan has been the CEO of the South African company since 2010. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The University of Manchester | College/University | Doctorate Degree | |
INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member | |
University College London Hospitals NHS Foundation Trust
![]() University College London Hospitals NHS Foundation Trust Hospital/Nursing ManagementHealth Services University College London Hospitals NHS Foundation Trust provides first-class acute and specialist services in six hospitals in central London, UK. The British company's mission is to deliver top-quality patient care, excellent education, and world-class research. The company also offers events, classes, and workshops at the Macmillan Support and Information Service (MSIS) and an audiological service for GPs who would like to refer patients for age-related audiological assessments. Additionally, the company provides information about the sarcoma service and hearing therapists who work with adults who have hearing loss and associated disorders, such as tinnitus and hyperacusis, and other forms of hypersensitivity. The company is ultimately controlled by the Government of United Kingdom. | Hospital/Nursing Management | Corporate Officer/Principal | |
HealthCor Management LP
![]() HealthCor Management LP Investment ManagersFinance HealthCor Management LP (HealthCor) is a holding firm and SEC-registered hedge fund manager headquartered in New York City. The firm was co-founded by Joseph Healey and Arthur Cohen in 2005. HealthCor provides investment management services to several privately offered pooled investment funds and institutional investors through separately managed accounts. | Investment Managers | Corporate Officer/Principal | |
Congenica Ltd.
![]() Congenica Ltd. BiotechnologyHealth Technology Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom. | Biotechnology | Founder | |
UCL Institute of Child Health | Corporate Officer/Principal | ||
Axovia Therapeutics, Inc.
![]() Axovia Therapeutics, Inc. BiotechnologyHealth Technology Part of Axovia Therapeutics Ltd., Axovia Therapeutics, Inc. is dedicated to developing disease-transformative therapies that target key aspects of ciliopathies. The American company is working to advance gene therapy programs that have already shown early promise in treating some of the most severe aspects of bbs, such as early onset blindness and neurometabolic disease. The company was founded by Philip Beales, Victor Hernandez, and Philip Beales has been the CEO since incorporation. Axovia Therapeutics was acquired by Alsa Management Services Ltd on September 19, 2023. | Biotechnology | Chief Executive Officer |
Statistiques
Internationale
Royaume-Uni | 9 |
Norvège | 2 |
Afrique du Sud | 2 |
France | 2 |
Etats-Unis | 2 |
Sectorielle
Finance | 5 |
Health Technology | 5 |
Commercial Services | 2 |
Consumer Services | 2 |
Health Services | 2 |
Opérationnelle
Director/Board Member | 5 |
Corporate Officer/Principal | 4 |
Analyst-Equity | 3 |
Founder | 3 |
Independent Dir/Board Member | 2 |
Relations les plus connectées
Insiders | |
---|---|
Sally Bennett | 10 |
Philip Beales | 4 |
- Bourse
- Insiders
- Nathan McNally
- Connexions Sociétés